A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis c: pretreatment stratification by viral burden and genotype.

Source:http://linkedlifedata.com/resource/pubmed/id/11095346

Download in:

View as

General Info

PMID
11095346